JSR adding European biologic manufacturing capacity in Geneva expansion 27-Oct-2020 By Nick Taylor JSR Life Sciences is set to add European biologic bulk drug substance manufacturing by opening a new KBI Biopharma facility in Geneva.
Novel manufacturing technologies ‘fit poorly’ into regulatory models, says EMA 05-Jul-2019 By Ben Hargreaves The EMA looks to the future by posting its five key priorities to address in the coming five years, which includes the need to recruit expertise in ‘novel manufacturing technologies’.
